Imatinib Recruiting Phase 1 Trials for Advanced Cancers Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01738139Ipilimumab and Imatinib Mesylate in Advanced Cancer